Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.32%
1,100.57
-3.53
-0.32%
—1,104.101,103.921,108.751,097.16——
SIXC
Communications
SIXC
Communications
SIXC
+0.16%
605.15
+0.99
+0.16%
—604.16604.16610.19604.12——
SIXE
Energy
SIXE
Energy
SIXE
-0.22%
1,195.19
-2.62
-0.22%
—1,197.811,200.581,213.071,192.02——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.03%
1,739.91
-0.50
-0.03%
—1,740.411,739.551,750.271,730.60——
SIXM
Financials
SIXM
Financials
SIXM
+0.65%
638.56
+4.12
+0.65%
—634.44633.13639.87633.01——
SIXR
Staples
SIXR
Staples
SIXR
-1.11%
831.57
-9.33
-1.11%
—840.90839.53841.73831.10——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.82%
213.36
-1.77
-0.82%
—215.13215.13215.85213.24——
SIXT
Technology
SIXT
Technology
SIXT
+0.17%
3,234.18
+5.47
+0.17%
—3,228.713,225.623,235.433,198.95——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.02%
935.65
-0.22
-0.02%
—935.87938.37942.00935.65——
SIXV
Health care
SIXV
Health care
SIXV
-0.54%
1,449.26
-7.86
-0.54%
—1,457.121,452.741,466.881,449.18——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,382.45
-17.39
-0.72%
—2,399.842,389.712,394.612,371.22——
BIM:EPA
BioMerieux SA
€70.85
-0.63%
(-0.45) 1D
Apr 28, 1:04:34 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for BIM...
Open
€71.30
High
€71.55
Low
€70.65
Mkt. cap
8.39B
Avg. vol.
150.93K
Volume
67.64K
P/E ratio
21.18
52-wk high
€128.30
52-wk low
€70.25
EPS
€3.34
Shares outstanding
118.36M
No. of employees
15K
News stories
From sources across the web
Profile
bioMérieux SA is a French multinational biotechnology company founded and headquartered in Marcy-l'Étoile, France, close to Lyon. bioMérieux is present in 44 countries and serves more than 160 countries through a large network of distributors. bioMérieux provides diagnostic solutions which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases, cancer screening, and monitoring and cardiovascular emergencies. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is listed on the Euronext Paris stock exchange. Wikipedia
About BioMerieux SA
CEOPierre Boulud
Employees14.9K
Founded1963
HeadquartersMarcy-l'Étoile, Rhone-Alpes, France
SectorMedical device
Websitebiomerieux.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
1.02B
1.02B
1.01B
1.01B
Cost of goods sold
438.45M
438.45M
442.05M
442.05M
Cost of revenue
438.45M
438.45M
442.05M
442.05M
Research and development expenses
124.70M
124.70M
129.00M
129.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
284.40M
284.40M
271.20M
271.20M
Operating expense
406.35M
406.35M
400.65M
400.65M
Total operating expenses
844.80M
844.80M
842.70M
842.70M
Operating income
177.10M
177.10M
170.30M
170.30M
Other non operating income
200.00K
200.00K
-
-
EBT including unusual items
106.60M
106.60M
156.25M
156.25M
EBT excluding unusual items
179.95M
179.95M
171.85M
171.85M
Income tax expense
26.30M
26.30M
38.10M
38.10M
Effective tax rate
24.67%
24.67%
24.38%
24.38%
Other operating expenses
-11.60M
-11.60M
-7.30M
-7.30M
Net income
80.50M
80.50M
118.25M
118.25M
Net profit margin
7.88%
7.88%
11.67%
11.67%
Earnings per share
-
-
-
-
Interest and investment income
3.85M
3.85M
3.30M
3.30M
Interest expense
-3.70M
-3.70M
-4.20M
-4.20M
Net interest expenses
150.00K
150.00K
-900.00K
-900.00K
Depreciation and amortization charges
-
-
7.75M
7.75M
EBITDA
237.85M
237.85M
327.00M
327.00M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer